Mohan S. Iyer

Managing Director

Mr. Iyer brings to Burrill & Company a broad background in a range of functions including business development, strategic planning, marketing, product development, engineering and manufacturing. Prior to joining Burrill & Company, he was Executive VP of Corporate Development at diaDexus where he was responsible for sourcing and executing various types of transactions for a seven-year period, including discovery collaborations, in-licensing, out-licensing, manufacturing/supply contracts, and a spin-out. He has extensive experience in diagnostics, including alliances with major national reference laboratories. He also sourced and closed a therapeutic monoclonal antibody co-development agreement with Medarex. While at diaDexus, Mr. Iyer played a key role in two private financings totaling over $130mm, managed R&D operations for a transition year, and headed the marketing launch of a novel cardiovascular diagnostic product. Prior to diaDexus, he was a healthcare consultant at The Wilkerson Group where he managed several strategic engagements across the pharmaceutical, biotech, diagnostics and medical device industries. Mr. Iyer began his biotech career as a biochemical process engineer at Genentech, where he spent 7 years in positions ranging from biopharmaceutical manufacturing to capital projects management. He holds a BS in Chemical Engineering (Tennessee), an MS in Biomedical Engineering (Duke), and an MBA (Yale).